Lv4
660 积分 2023-06-19 加入
Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
3小时前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
2个月前
已完结
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
3个月前
已完结
The Drug-Dosing Conundrum in Oncology — When Less Is More
3个月前
已完结
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
3个月前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
4个月前
已完结
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer
4个月前
已完结
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
4个月前
已完结
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer
4个月前
已完结
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
4个月前
已完结
皖公网安备34019202002308
